Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANDY study of high-dose versus standard-dose clopidogrel in type 2 diabetes after drug-eluting stent PCI
2007-003907-11Phase 4Active
- Sponsor
- Instituto Clodomiro Picado
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in acute coronary syndrome (ACS) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Instituto Clodomiro Picado. Primary endpoint: Platelet response threshold. Started Jan 2008; status: active.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-003907-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003907-11.